Related Experiment Video

Updated: Oct 4, 2025

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells
14:26

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells

Published on: April 4, 2016

25.5K

The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy

Eric van Leen1,2, Lotte Brückner3, Anton G Henssen4,5,6,7,8

  • 1Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Nature Genetics
|February 11, 2022
PubMed

Insights

Extrachromosomal DNA (ecDNA) amplifies in many cancers, impacting patient outcomes. Emerging research shows ecDNA may disrupt gene expression and offers new targets for cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Extrachromosomal DNA (ecDNA) amplification is prevalent in over 30 cancer types, correlating with poor patient prognosis.
  • ecDNA is known to increase oncogene dosage by harboring both oncogenes and enhancers.
  • Recent findings suggest ecDNA's role extends beyond oncogene dosage, potentially disrupting genome-wide gene expression.

Purpose of the Study:

  • To explore the emerging properties of extrachromosomal DNA (ecDNA) in cancer.
  • To investigate the potential of ecDNA to disrupt genome-wide gene expression.
  • To highlight novel therapeutic strategies targeting ecDNA in cancer treatment.

Main Methods:

  • Review of recent investigations into ecDNA localization and function.
  • Analysis of data suggesting ecDNA acts as ectopic enhancers in nuclear bodies (hubs).
  • Consideration of ecDNA reintegration into the host genome.

Main Results:

  • ecDNA may function as trans-acting enhancers within nuclear hubs, affecting genes on other ecDNA or chromosomes.
  • ecDNA reintegration into the genome is a potential mechanism for further disrupting tumor cell gene regulation.
  • These findings expand the understanding of ecDNA's impact on the tumor regulatory landscape.

Conclusions:

  • Extrachromosomal DNA (ecDNA) has emerging properties that extend beyond oncogene amplification.
  • ecDNA's ability to act as ectopic enhancers and reintegrate into the genome presents new avenues for cancer disruption.
  • Exploiting these ecDNA characteristics offers promising strategies for developing novel, targeted cancer therapies.

More Related Videos

Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens03:55

Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens

Published on: July 12, 2024

1.6K
Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA11:58

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

Published on: June 25, 2014

30.4K

Related Concept Videos

Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
23.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
8.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.0K